Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TRILLION ENERGY ANNOUNCES 2022 YEAR END RESERVE REPORT (click to learn more) Fokus Releases An Initial Mineral Resource Estimate On Galloway Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Healthcare Drug Manufacturers - Major
Revive has built a robust product pipeline that has a particular focus on infectious diseases and rare disorders and is discovering and developing new therapeutic uses of drugs such as Bucillamine, Psilocybin and Cannabidiol. We are steadily advancing our product development programs that will unlock the potential value of Revive and we are continuing to expand our product pipeline in infectious diseases and rare disorders.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:RVV)

Fundamentals Snapshot (CSE:RVV)

Current News (CSE:RVV)

Revive Therapeutics (CSE:RVV) updates on Phase 3 clinical study for Bucillamine

Research 3 days ago

Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

GlobeNewswire 3 days ago

Revive Therapeutics (CSE:RVV) revising Bucillamine study endpoints

Caroline Egan  March 8, 2023

Revive Therapeutics Provides Update From Type C Meeting with FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

GlobeNewswire March 8, 2023

Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal Patch Development

GlobeNewswire February 6, 2023

PharmAla Named Exclusive MDMA Supplier to Revive Therapeutics

GlobeNewswire February 6, 2023

Revive Therapeutics (CSE:RVV) & PharmaTher (CSE:PHRM) sign MDMA research collaboration agreement

Jon Brown February 3, 2023

Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch

GlobeNewswire February 3, 2023

Revive Therapeutics Submits Updated Briefing Package in Support of Upcoming Type C Meeting Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

GlobeNewswire January 19, 2023
View More News ››

Opinion & Analysis (CSE:RVV)

A Potential Psychedelic and COVID Therapy Play…All in One Stock

Dave Jackson June 18, 2020

Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19

Streetwise Reports June 4, 2020
View More Opinion ››

Bullboard Posts (CSE:RVV)

RE:$RVV - fyi !

Would this be a good entry point for newbies? Is RVV derisked enough as it stands? Does it have enough cash to continue even with the...
G1945V - 1 day ago

$RVV - fyi !

#Bucillamine - Just wait for the B/O ! https://newsytrends.com/2023/03/20/revive-therapeutics-ltd-cse-rvv-otcmkts-rvvtf-reverses-off-52...
cool888 - 2 days ago

RE:RE:Cool888

The time will tell part is over.
1ottrunner - 2 days ago

RE:Cool888

#Bucillamine  Time will tell  bro  !!!!
cool888 - 2 days ago

RE:RE:RE:when zero

I called it another frank bust out,they have have to ban this guy
hashboy18 - 3 days ago

Cool888

How about now? Imagine if you had all taken your money out of this and bought btc like a mentioned a few months the ago. Good luck all....
1ottrunner - 3 days ago
View more Bullboard ››

Fuse Battery Metals Inc.

Fuse Battery Metals Inc.

Fuse Cobalt is a Canada-based company engaged in the exploration and development of exploration and evaluation properties ...
View More »